Riskpilot← Back to searchSign inGet full accessNEW NORDIC AS
ASActiveOrg 982754437Glassverket 35, 1515 MossWholesale of other food · NACE 4638Est. 20005 employeeswww.newnordic.no
Revenue 2025
NOK 29,9M
+5% vs 2024
EBITDA margin
2.3%
-19% vs 2024
Equity ratio
41.9%
Financial strength
Net profit 2025
NOK 536K
-18% vs 2024
| Revenue | NOK 29,9M | +5% |
| EBITDA | NOK 676K | -19% |
| Net profit | NOK 536K | -18% |
| Total assets | NOK 9,4M | +22% |
| Equity | NOK 3,9M | -11% |
| Employees | 5 | — |
Legal name
NEW NORDIC AS
Org number
982754437
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
18. desember 2000
Share capital
NOK 300 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Salg av legemidler, næringsmidler herunder kosttilskudd samt ved erverv av aksjer eller på annen måte å gjøre seg interessert i andre foretagende av samme eller lignende art.
Address
Glassverket 35, 1515 Moss
Phone
+4769257300
Email
info@newnordic.no
Website
www.newnordic.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 24 768 | 20 673 | 26 186 | 28 480 | 29 916 |
| Staff expenses | −2 664 | −2 408 | −3 025 | −3 315 | −3 379 |
| EBITDA | 504 | 420 | 647 | 839 | 676 |
| Depreciation & amort. | −7 | −5 | −5 | −5 | −3 |
| EBIT | 497 | 415 | 642 | 834 | 673 |
| Net financials | −44 | −48 | 0 | 4 | 26 |
| Profit before tax | 453 | 368 | 642 | 838 | 699 |
| Tax | 100 | 81 | 148 | 183 | 163 |
| Net profit | 354 | 287 | 494 | 655 | 536 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 246 | 6 207 | 8 141 | 7 730 | 9 411 |
| Equity | 3 575 | 3 862 | 4 356 | 4 411 | 3 947 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 670 | 2 345 | 3 785 | 3 319 | 5 463 |
| Total debt | 3 670 | 2 345 | 3 785 | 3 319 | 5 463 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20212025
Equity ratio
41.9%
This company
38.2%
Market median
+10% vs market
20212025
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20212025
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20212025
Asset turnover
3.18×
This company
1.12×
Market median
+184% vs market
20212025
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TC Chief Executive Officer | Chief Executive Officer | 2002 |
| Former (1) | ||
TC Chief Executive Officer | Chief Executive Officer | 2002 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2006 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
New Nordic Healthbrands Ab | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEW NORDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Therese Christin Wærnes | Chief Executive Officer | 0 companies |
| Therese Christin Wærnes Foldvik | Chief Executive Officer | 0 companies |
| Marinus Blaabjerg Sørensen | Board of Directors | 0 companies |
| Karl Kristian Jensen | Chairman | 0 companies |